{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:44:05Z","timestamp":1792039445239,"version":"4.4.0"},"reference-count":40,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.3892\/ijo.2016.3334","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T11:09:30Z","timestamp":1452683370000},"page":"1218-1228","source":"Crossref","is-referenced-by-count":13,"title":["The antitumor efficacy of a novel adenovirus-mediated anti-p21Ras single chain fragment variable antibody on human cancers in vitro and in vivo"],"prefix":"10.3892","volume":"48","author":[{"given":"JU-LUN","family":"YANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIN-YAN","family":"PAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN-XING","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QI-CHAN","family":"HU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FENG","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QIANG","family":"FENG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUI-YUN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YING","family":"LUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"key20180107185011_b1-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107185011_b2-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"Fern\u00e1ndez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"key":"key20180107185011_b3-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/300149a0","article-title":"A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene","volume":"300","author":"Reddy","year":"1982","journal-title":"Nature"},{"key":"key20180107185011_b4-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/93.14.1062","article-title":"Blocking oncogenic Ras signaling for cancer therapy","volume":"93","author":"Adjei","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"key20180107185011_b5-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"key20180107185011_b6-ijo-48-03-1218","first-page":"1170","article-title":"Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression","volume":"58","author":"Cochet","year":"1998","journal-title":"Cancer Res"},{"key":"key20180107185011_b7-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1128\/MCB.14.6.4193","article-title":"Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton","volume":"14","author":"Prendergast","year":"1994","journal-title":"Mol Cell Biol"},{"key":"key20180107185011_b8-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm0895-792","article-title":"Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice","volume":"1","author":"Kohl","year":"1995","journal-title":"Nat Med"},{"key":"key20180107185011_b9-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/jnci\/94.13.1031","article-title":"Re: Blocking oncogenic Ras signaling for cancer therapy","volume":"94","author":"Canevari","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"key20180107185011_b10-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/j.1460-2075.1995.tb07140.x","article-title":"Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies","volume":"14","author":"Mhashilkar","year":"1995","journal-title":"EMBO J"},{"key":"key20180107185011_b11-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1073\/pnas.91.11.5075","article-title":"Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody","volume":"91","author":"Duan","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185011_b12-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1172\/JCI118370","article-title":"Targeted tumor killing via an intracellular antibody against erbB-2","volume":"96","author":"Deshane","year":"1995","journal-title":"J Clin Invest"},{"key":"key20180107185011_b13-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0161-5890(98)00105-9","article-title":"Intracellular expression and functional properties of an anti-p21Ras scFv derived from a rat hybridoma containing specific lambda and irrelevant kappa light chains","volume":"35","author":"Cochet","year":"1998","journal-title":"Mol Immunol"},{"key":"key20180107185011_b14-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1432-1327.2000.01125.x","article-title":"Diverting a protein from its cellular location by intracellular antibodies","volume":"267","author":"Lener","year":"2000","journal-title":"Eur J Biochem"},{"key":"key20180107185011_b15-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1947601911412376","article-title":"Therapeutic strategies for targeting ras proteins","volume":"2","author":"Gysin","year":"2011","journal-title":"Genes Cancer"},{"key":"key20180107185011_b16-ijo-48-03-1218","first-page":"5239","article-title":"Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment","volume":"59","author":"Russell","year":"1999","journal-title":"Cancer Res"},{"key":"key20180107185011_b17-ijo-48-03-1218","first-page":"2295","article-title":"Isolated limb perfusion based anti-p21ras gene therapy in a rat rhabdomyosarcoma","volume":"24","author":"Van Etten","year":"2004","journal-title":"Anticancer Res"},{"key":"key20180107185011_b18-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.radonc.2013.06.023","article-title":"Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells","volume":"108","author":"Saki","year":"2013","journal-title":"Radiother Oncol"},{"key":"key20180107185011_b19-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/311562a0","article-title":"Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases","volume":"311","author":"Thor","year":"1984","journal-title":"Nature"},{"key":"key20180107185011_b20-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02925993","article-title":"Overexpression of c-Ki-ras and c-fos in human pancreatic carcinomas","volume":"11","author":"Wakita","year":"1992","journal-title":"Int J Pancreatol"},{"key":"key20180107185011_b21-ijo-48-03-1218","first-page":"627","article-title":"Ras p21 overexpression is a late event in prostate-cancer","volume":"4","author":"Hamdy","year":"1994","journal-title":"Int J Oncol"},{"key":"key20180107185011_b22-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.oraloncology.2011.12.006","article-title":"Ras oncogenes in oral cancer: The past 20 years","volume":"48","author":"Murugan","year":"2012","journal-title":"Oral Oncol"},{"key":"key20180107185011_b23-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.celrep.2015.06.044","article-title":"Wild-Type N-Ras, Overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL-8 Secretion via JAK2 activation","volume":"12","author":"Zheng","year":"2015","journal-title":"Cell Reports"},{"key":"key20180107185011_b24-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1073\/pnas.81.16.5227","article-title":"Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas","volume":"81","author":"Hand","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185011_b25-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jnci\/81.1.63","article-title":"Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas","volume":"81","author":"Gerosa","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"key20180107185011_b26-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00043764-199604000-00017","article-title":"Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer","volume":"38","author":"Novara","year":"1996","journal-title":"J Occup Environ Med"},{"key":"key20180107185011_b27-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat Protoc"},{"key":"key20180107185011_b28-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1074\/jbc.271.3.1364","article-title":"Activation of the integrin alpha v beta 3 involves a discrete cation-binding site that regulates conformation","volume":"271","author":"Pelletier","year":"1996","journal-title":"J Biol Chem"},{"key":"key20180107185011_b29-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2009.05.006","article-title":"E1B-55kD-deleted oncolytic adenovirus armed with canstatin gene yields an enhanced anti-tumor efficacy on pancreatic cancer","volume":"285","author":"He","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180107185011_b30-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/1756-0500-5-483","article-title":"Altered specificity of single-chain antibody fragments bound to pandemic H1N1-2009 influenza virus after conversion of the phage-bound to the soluble form","volume":"5","author":"Kaku","year":"2012","journal-title":"BMC Res Notes"},{"key":"key20180107185011_b31-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"24500","DOI":"10.1074\/jbc.M110.211847","article-title":"Production and characterization of a humanized single-chain antibody against human integrin alphav beta3 protein","volume":"286","author":"Liu","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107185011_b32-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/j.1460-2075.1990.tb08085.x","article-title":"Expression and targeting of intracellular antibodies in mammalian cells","volume":"9","author":"Biocca","year":"1990","journal-title":"EMBO J"},{"key":"key20180107185011_b33-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-662-07992-8","volume-title":"Intracellular Antibodies: Development and Applications","author":"Cattaneo","year":"1997"},{"key":"key20180107185011_b34-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1089\/hum.2009.163","article-title":"The current state of head and neck cancer gene therapy","volume":"20","author":"Thomas","year":"2009","journal-title":"Hum Gene Ther"},{"key":"key20180107185011_b35-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1006\/bbrc.1993.2496","article-title":"Intracellular expression of anti-p21ras single chain Fv fragments inhibits meiotic maturation of xenopus oocytes","volume":"197","author":"Biocca","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107185011_b36-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1073\/pnas.90.16.7889","article-title":"Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody","volume":"90","author":"Marasco","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185011_b37-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.micro.51.1.257","article-title":"Intracellular antibodies (intrabodies) for gene therapy of infectious diseases","volume":"51","author":"Rondon","year":"1997","journal-title":"Annu Rev Microbiol"},{"key":"key20180107185011_b38-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1073\/pnas.96.21.11723","article-title":"Selection of antibodies for intracellular function using a two-hybrid in vivo system","volume":"96","author":"Visintin","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107185011_b39-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2009.09.022","article-title":"Selective targeting of HPV-16 E6\/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo","volume":"291","author":"Wang","year":"2010","journal-title":"Cancer Lett"},{"key":"key20180107185011_b40-ijo-48-03-1218","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2012.08.032","article-title":"Adenovirus vector-mediated expression of TMEM166 inhibits human cancer cell growth by autophagy and apoptosis in vitro and in vivo","volume":"328","author":"Chang","year":"2013","journal-title":"Cancer Lett"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3334\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T14:04:38Z","timestamp":1654092278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,13]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,1,13]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.3892\/ijo.2016.3334"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3334","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,13]]}}}